Drug research

ADX-629

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic CoughNCT05392192	ALDX	Phase 2	Completed	2023-04-13Actual
A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics for the Treatment of COVID-19.NCT04847544	ALDX	Phase 2	Completed	2021-10-15Actual
A Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Subjects With Plaque PsoriasisNCT04908514	ALDX	Phase 2	Completed	2022-01-21Actual
A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficacy of Subjects With Mild Asthma Induced by the Bronchial Allergen Challenge (BAC)NCT04728711	ALDX	Phase 2	Completed	2022-01-18Actual
A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1)NCT06685692	ALDX	Phase 2	Completed	2025-06-18Actual

ALDXCompletedPrimary completion: 2023-04-13 · Actual

Trial details

ALDXCompletedPrimary completion: 2021-10-15 · Actual

Trial details

ALDXCompletedPrimary completion: 2022-01-21 · Actual

Trial details

ALDXCompletedPrimary completion: 2022-01-18 · Actual

Trial details

ALDXCompletedPrimary completion: 2025-06-18 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.